Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-03-24

Clinical Trial Update: Selecting Treatment in Colorectal Cancer:Capecitabine or 5-fluorouracil Selection to be Combined With Oxaliplatin or Irinotecan as First-line Chemotherapy in Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial investigates first-line chemotherapy options for advanced colorectal cancer. It compares capecitabine versus 5-fluorouracil when combined wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Capecitabine (capecitabine)
  • Irinotecan (Irinotecan)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED